Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study. Issue 6 (June 2013)
- Record Type:
- Journal Article
- Title:
- Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study. Issue 6 (June 2013)
- Main Title:
- Individualized tumor response testing profile has a prognostic value in childhood acute leukemias: multicenter non-interventional long-term follow-up study
- Authors:
- Piatkowska, Magdalena
Styczynski, Jan
Kolodziej, Beata
Kurylo-Rafinska, Beata
Kubicka, Malgorzata
Pogorzala, Monika
Czyzewski, Krzysztof
Debski, Robert
Matysiak, Michal
Malinowska, Iwona
Balwierz, Walentyna
Juraszewska, Edyta
Wachowiak, Jacek
Konatkowska, Benigna
Wieczorek, Maria
Olejnik, Igor
Krawczuk-Rybak, Maryna
Kuzmicz, Marta
Kowalczyk, Jerzy
Stefaniak, Maria Jolanta
Badowska, Wanda
Szczepanski, Tomasz
Tomaszewska, Renata
Adamkiewicz-Drozynska, Elżbieta
Maciejka-Kapuscinska, Lucyna
Sobol, Grazyna
Mizia-Malarz, Agnieszka
Wysocki, Mariusz - Abstract:
- Abstract: A total number of 817 children with acute lymphoblastic leukemia (ALL) and 181 with acute myeloblastic leukemia (AML) were assessed for individualized tumor response testing (ITRT) profile as a prognostic factor in long-term follow-up. For each patient, ITRT, initial response to therapy and long-term outcome were assessed. In initial ALL, an impact on long-term response was shown in ITRT for 13 drugs, while in initial AML only for cytarabine. For patients with ALL, a combined five-drug ITRT profile for prednisolone, l -asparaginase, vincristine, cytarabine and daunorubicin or doxorubicin had predictive value for probability of disease-free survival (pDFS) in univariate analysis, whereas in multivariate analysis, bone marrow response by day 33 was the only prognostic factor. For patients with AML, no factor had prognostic value for pDFS in univariate analysis, while ITRT to cytarabine almost reached significance. In conclusion, ITRT can possibly be regarded as a risk factor in childhood acute leukemias.
- Is Part Of:
- Leukemia & lymphoma. Volume 54:Issue 6(2013:Jun.)
- Journal:
- Leukemia & lymphoma
- Issue:
- Volume 54:Issue 6(2013:Jun.)
- Issue Display:
- Volume 54, Issue 6 (2013)
- Year:
- 2013
- Volume:
- 54
- Issue:
- 6
- Issue Sort Value:
- 2013-0054-0006-0000
- Page Start:
- 1256
- Page End:
- 1262
- Publication Date:
- 2013-06
- Subjects:
- Drug resistance -- individualized tumor response testing -- children -- acute lymphoblastic leukemia -- acute -- myeloid leukemia
Leukemia -- Periodicals
Lymphomas -- Periodicals
616.99419 - Journal URLs:
- http://informahealthcare.com ↗
- DOI:
- 10.3109/10428194.2012.741231 ↗
- Languages:
- English
- ISSNs:
- 1042-8194
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5185.251500
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 9638.xml